2018
DOI: 10.1016/j.yrtph.2018.02.017
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo safety studies of cinnamon extract ( Cinnamomum cassia ) on general and genetic toxicology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 44 publications
(28 citation statements)
references
References 47 publications
2
26
0
Order By: Relevance
“…As pointed by Memar et al [ 23 ], knowing the mechanism of action of the essential oils is one thing, but to achieve a clinical use, the research of the toxicity should not be forgotten. E-cinnamaldehyde is known to present toxicity against cancer cell lines but also against normal cell lines, as observed in the present study [ 25 , 26 ]. As mentioned before, the results regarding Chinese cinnamon should be carefully interpreted.…”
Section: Discussionsupporting
confidence: 58%
“…As pointed by Memar et al [ 23 ], knowing the mechanism of action of the essential oils is one thing, but to achieve a clinical use, the research of the toxicity should not be forgotten. E-cinnamaldehyde is known to present toxicity against cancer cell lines but also against normal cell lines, as observed in the present study [ 25 , 26 ]. As mentioned before, the results regarding Chinese cinnamon should be carefully interpreted.…”
Section: Discussionsupporting
confidence: 58%
“…Later, in a randomized controlled trial of C. cassia hemoglobin A1C reduction in patients with type 2 diabetes, the treatment group received two C. cassia capsules (500 mg each) per day for 90 days, and one of the subjects developed a rash, which subsided after discontinuation, but no further adverse reactions were observed [110]. In 2018, a 13-week repeat-dose oral toxicity study revealed that body weights of rats were normal, the weight of kidney/live and the level of total cholesterol were increased after receiving WEBC at up to 2000 mg/kg, but it was not mutagenic or clastogenic [111]. Later, a 8-week repeat-dose oral toxicity study revealed that renal function showed a significant increase, kidney and liver histology showed distortions in hepatocytes and sinusoidal linings with infiltrations, degenerative changes in glomerular and Bowman’s capsules with fibrillary mesangial interstitium after receiving CcAgNPs at up to 200 mg/kg [112].…”
Section: Toxicitymentioning
confidence: 99%
“…These findings were in line with previous studies who reported the inhibitory effect of nanoparticles which hinder the antioxidative system. [31][32][33] Although after the CMBE supplementations with pre-treatment of Ni-NPs we observed considerable improvements in antioxidant levels (CAT and GSH) and reduction of the oxidation by-products (LPO and MDA) in liver and kidneys than only Ni-NPs treated group (NG). The antioxidant properties of C. cassia against Ni-NPs-induced oxidative stress was similar to findings of Shakeel et al 14 who reported a significant dose-dependent decrease of MDA and increase of anti-oxidant enzymes GPX, SOD, and CAT due to C. cassia oral administration in titanium oxide (TiO 2 NPs) exposed Sprague Dawley rats.…”
Section: Discussionmentioning
confidence: 99%